UPDATE: Citi Downgrades Syndax Pharmaceuticals (SNDX) to Neutral
Tweet Send to a Friend
(Updated - May 18, 2020 7:03 AM EDT)
(updating comment)Citi analyst Joel Beatty downgraded Syndax Pharmaceuticals (NASDAQ: SNDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Citi analyst Joel Beatty downgraded Syndax Pharmaceuticals (NASDAQ: SNDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
